International Business News - Durect http://www.ibtimes.com All articles are copyrighted by IBTimes.com 400 100 http://www.ibtimes.com/ http://www.ibtimes.com/images/top_logo_ibt2_3.gif Drug developer Durect Corp. said Tuesday it applied for regulatory approval of Remoxy, designed to be an abuse-resistant form of oxycodone. The company submitted a new drug application to the U.S. Food and Drug Administration to use Remoxy, an investigational drug, as a long-acting oral form of oxycodone, as a treatment for moderate to severe pain. http://www.ibtimes.com/articles/20080610/durect-submits-new-drug-application-for-remoxy.htm Tue, 10 Jun 2008 18:39:46 EDT Shares of drug developer Durect Corp. surged Thursday, after the company reported a smaller first-quarter loss on lower costs and greater research and development partnership revenue. http://www.ibtimes.com/articles/20080508/durect-shares-rise-following-solid-1q-financial-results.htm Thu, 08 May 2008 18:41:50 EDT Among the earnings stories for Wednesday, May 7, from AP Financial News: CUPERTINO, Calif. (AP) _ Pharmaceutical company Durect Corp. said Wednesday its loss narrowed in the first quarter, helped by lower costs and a rise in revenue from research and development partnerships. http://www.ibtimes.com/articles/20080507/earnings-roundup-durect-arena-pharmaceuticals.htm Wed, 07 May 2008 19:01:45 EDT Durect Corp. said late Monday Endo Pharmaceuticals has decided to return the rights to implantable pain reliever Chronogesic, which it licensed from the company for the U.S. and Canada. Chronogesic ... http://www.ibtimes.com/articles/20080407/endo-returns-pain-device-right-to-durect.htm Mon, 07 Apr 2008 18:11:52 EDT